AN2 Therapeutics, Inc.
ANTX
$1.07
-$0.06-5.31%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -19.80% | -10.50% | -10.63% | -8.47% | 6.44% |
| Total Receivables | 0.00% | -70.00% | 233.33% | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -6.19% | -28.16% | 25.60% | 23.54% | 16.06% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -19.36% | -11.70% | -9.07% | -7.63% | 5.25% |
|
|
|||||
| Total Current Assets | -19.36% | -11.70% | -9.07% | -7.63% | 5.25% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -62.19% | -- | -- | 0.00% | 0.00% |
| Total Assets | -11.67% | -5.73% | -9.95% | -10.54% | -12.60% |
|
|
|||||
| Total Accounts Payable | -7.36% | 93.86% | -9.23% | -22.52% | -9.08% |
| Total Accrued Expenses | -25.42% | -12.81% | -8.49% | -2.86% | -26.08% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -53.35% | -37.96% | 128.09% | 74.14% | -51.95% |
| Total Other Current Liabilities | -53.35% | -37.96% | 128.09% | 74.14% | -51.95% |
| Total Current Liabilities | -21.72% | 2.21% | -1.09% | -5.03% | -24.07% |
|
|
|||||
| Total Current Liabilities | -21.72% | 2.21% | -1.09% | -5.03% | -24.07% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -21.72% | 2.21% | -1.09% | -5.03% | -24.07% |
|
|
|||||
| Common Stock & APIC | 0.73% | 0.62% | 0.68% | 0.81% | 0.98% |
| Retained Earnings | -5.18% | -3.79% | -6.87% | -8.44% | -10.76% |
| Treasury Stock & Other | 54.84% | -72.32% | 514.81% | -150.94% | -80.73% |
| Total Common Equity | -10.41% | -6.64% | -10.86% | -11.07% | -11.31% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -10.41% | -6.64% | -10.86% | -11.07% | -11.31% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -10.41% | -6.64% | -10.86% | -11.07% | -11.31% |
|
|
|||||